Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
62.6M
-
Shares change
-
+3.55M
-
Total reported value, excl. options
-
$2.17B
-
Value change
-
+$118M
-
Put/Call ratio
-
1.62
-
Number of buys
-
73
-
Number of sells
-
-112
-
Price
-
$34.75
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2020
241 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2020.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.6M shares
of 101M outstanding shares and own 62% of the company stock.
Largest 10 shareholders include FMR LLC (9.81M shares), VANGUARD GROUP INC (7.13M shares), BlackRock Inc. (7.02M shares), PRIMECAP MANAGEMENT CO/CA/ (5.02M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (3.96M shares), JANUS HENDERSON GROUP PLC (3.08M shares), STATE STREET CORP (2.66M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.05M shares), FARALLON CAPITAL MANAGEMENT LLC (1.6M shares), and FIRST TRUST ADVISORS LP (1.32M shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.